Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Announces That Repotrectinib Granted Priority Review By China’S NMPA

May 18 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB ANNOUNCES THAT REPOTRECTINIB GRANTED PRIORITY
REVIEW BY
CHINA’S NMPA

Source text for Eikon:  ID:nGNX1KG6k4 
Further company coverage:  9688.HK

Recent news on Zai Lab

See all news